Related Experiment Video

Updated: Apr 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K

Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

Antonio Frontera1, D G Wilson2, H Sekhon3

  • 1Department of Cardiology, Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, Marlborough Street, Bristol, BS2 8HW, UK. a.frontera@gmail.com.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|July 3, 2015
PubMed

Insights

Hypertrophic cardiomyopathy patients with atrial fibrillation face risks of embolic stroke. This study clarifies anticoagulation needs for this population.

Area of Science:

  • Cardiology
  • Genetics
  • Neurology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart condition.
  • Atrial fibrillation (AF) is the most common arrhythmia in HCM patients.
  • Limited research exists on AF, embolic stroke, and anticoagulation in HCM.

Purpose of the Study:

  • To investigate the relationship between AF and embolic stroke in HCM patients.
  • To clarify the prognostic significance of AF in the context of HCM.
  • To provide insights into anticoagulation requirements for HCM patients with AF.

Main Methods:

  • Review of existing literature on hypertrophic cardiomyopathy, atrial fibrillation, and embolic stroke.
  • Analysis of sparse data regarding sample sizes and prognostic significance.
  • Focus on understanding anticoagulation needs.

Main Results:

  • Atrial fibrillation is a frequent complication in hypertrophic cardiomyopathy.
  • Research on embolic stroke risk and anticoagulation in this cohort is limited.
  • The prognostic impact of AF in HCM requires further elucidation.

Conclusions:

  • HCM patients with AF may have an increased risk of embolic stroke.
  • Further research is crucial to establish definitive anticoagulation guidelines.
  • Understanding anticoagulation needs is vital for managing HCM patients with AF.

Keywords:
AnticoagulationAtrial fibrillationEmbolic strokeHypertrophic cardiomyopathy

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

3.2K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.0K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
326